RXWell to Decrease Post-Operative Opioid Use in Total Knee or Hip Arthroplasty
Recruiting now · Not applicable
Conditions studied: Mood Disorders, Anxiety, Depressive Symptoms, Depression, Anxiety Disorders, Anxiety Depression
In brief
It is envisioned that multipronged benefits from this pilot work for the UPMC ISD and its members. It is expected the RxWell platform to provide the following benefits: expansion of the use of RxWell to all UPMC ISD members providing peri-operative mood management with advantage of improved peri-operative outcomes, improving saving for the UPMC ISD by hastening the recovery and decreased resource utilization, and addition to the high-value care of UPMC with this holistic approach to patient perioperative care
Key facts
- Study ID
- NCT05658796
- Run by
- University of Pittsburgh
- People needed
- 150
- Starts
- 2023-01-27
- Expected to finish
- 2026-12-30
- Last updated by the study team
- 2026-06-03
Who can join
Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
Where it is running
- UPMC East — Monroeville, Pennsylvania, United States (enrolling)
- UPMC Shadyside — Pittsburgh, Pennsylvania, United States (enrolling)
- UPMC Passavant — Pittsburgh, Pennsylvania, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.